Home/ Supplements/ Niacin/ Dethroner Pre-Workout Pineapple Mango Co...

Dethroner Pre-Workout Pineapple Mango Coconut

product on market Powder Ekkovision Safety: 99/100
99/100

This product looks safe

  • Vitamin B3: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)
  • 44% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile includes B vitamins and magnesium, which support energy metabolism and muscle function with strong research backing. Sodium helps maintain fluid balance and nerve signaling during physical exertion. Overall, these ingredients are well-studied, though the specific evidence coverage for this formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Dethroner Pre-Workout Pineapple Mango Coconut
Open Full PDF View on NIH DSLD →
Details

Label Data

20.4 Gram(s)
Serving Size
20
Servings
Other Combinations
Product Type
44%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

40 mg NE (250% DV)
Exceeds UL by 1.1× (UL: 35 mg) 196 studies (A:5, B:63)
5 mg (295% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
50 mcg (2085% DV)
20.8× RDA — above typical dose 139 studies (A:1, B:44)
42 mg (10% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
Sodium
200 mg (8% DV)
10000 mg
Market median: 2000.0mg (275 products)
BetaPower
5000 mg
4000 mg
Market median: 1500.0mg (104 products) 21 studies (A:0, B:2)
3000 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
3000 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
NO3-T
2000 mg
NO3-T
2000 mg
VasoDrive-AP
1000 mg
1000 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
CocOganic Plus
1000 mg
1.1× RDA — within safe limits 38 studies (A:1, B:7)
SantEnergy Nu
400 mg
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)
Theobromine
300 mg
Nutricog
300 mg
Cognizin
250 mg
Infinergy
108.1 mg
Advantra Z
100 mg
25 mg
Market median: 100.0mg (116 products) 18 studies (A:0, B:3)
Bioperine
10 mg

Other Ingredients

Malic Acid Citric Acid Silicon Dioxide Natural & Artificial Flavors Sucralose Acesulfame Potassium
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Warnings & Precautions

Allergen: Contains: Milk, coconut.

Additional Information

Servings per container: 20 40

Metadata

Product Details

DSLD Entry Date2025-01-23
Product TypeOther Combinations
FormPowder
DSLD ID328487
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.